Back to search

Article

Dolutegravir-Based Therapy is Essential in Achieving HIV Epidemic Control in Low- and Middle-Income Countries: Real-Life Evidence from a Large Clinical Cohort in Cameroon

2026-01-12

Abstract excerpt

<title>Abstract</title> <p> <bold>BACKGROUND:</bold> HIV treatment has significantly improved with the introduction of potent antiretroviral therapy (ART), particularly dolutegravir (DTG)-based regimens. With suboptimal adherence reported in resource-limited settings (RLS), real-word evidence on DTG-effectiveness within ART clinics is limited. This study assessed virological response, drug resistance profiling...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cd2d3255-34a3-523d-a32a-610d66afa823
DOI
10.21203/rs.3.rs-8290769/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dolutegravir-Based Therapy is Essential in Achieving HIV Epidemic Control in Low- and Middle-Income Countries: Real-Life Evidence from a Large Clinical Cohort in CameroonDOI 10.21203/rs.3.rs-8290769/v1
Factors associated with viral load suppression among Children and Adolescents on Dolutegravir based Antiretroviral regime in Tanzania: a longitudinal analysisSemantic proximity
HIV-1 drug resistance in people on dolutegravir-based ART: Collaborative analysis of cohort studiesSemantic proximity
Monitoring of virological response and acquired HIV-1 drug resistance among patients initiating antiretroviral therapy in the Centre Region of Cameroon.Semantic proximity
Virological Outcomes and Dolutegravir Resistance Mutations in HIV-infected Patients: A Multicenter Retrospective Cohort Study in MozambiqueSemantic proximity
High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries.Semantic proximity
Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens.Semantic proximity
Acquired HIV-1 drug resistance to reverse transcriptase and protease inhibitors among people failing antiretroviral therapy in Cameroon and implications for future treatment options.Semantic proximity
HIV VIRAL SUPPRESSION AND ASSOCIATED FACTORS AMONG CHILDREN AND ADOLESCENTS ON A DOLUTEGRAVIR (DTG) BASED ANTIRETROVIRAL REGIMEN IN TANZANIA MAINLANDSemantic proximity
High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es Salaam.Semantic proximity
Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor‐ to dolutegravir‐based antiretroviral therapy: A prospective cohort study in Lesotho (DO‐REAL study)Semantic proximity
HIV Dolutegravir Resistance and Multiclass Failure in Mozambique: Findings from a Real-World CohortSemantic proximity
HIV viral non-suppression and drug resistance among persons who inject drugs on dolutegravir antiretroviral therapy in KenyaSemantic proximity
Select a neighboring publication to make it the new centre.